Pharmaceutical giant Pfizer’s CEO Albert Bourla has been found guilty of making “misleading” statements regarding his company’s COVID-19 vaccines.
The UK’s pharmaceutical regulator has determined that Bourla made “misleading” public claims about the vaccination of children.
However, Bourla stated last year at the Atlantic Council that people who spread Covid vaccine “misinformation” are “criminals.”
He made the statement while calling for censorship of so-called “misinformation” online.
Last December, in an interview with the BBC, Dr. Bourla said that “there is no doubt in my mind that the benefits, completely, are in favor of” vaccinating children between the ages of five and 11.
“Covid in schools is thriving,” the multi-billionaire Big Pharma boss continued.
“This is disturbing, significantly, the educational system and there are kids that will have severe symptoms.”
The interview was conducted before the vaccine was approved for children between the ages of five and 11 in the UK.
After the interview was published, the parental rights campaign group UsForThem filed a complaint with the Prescription Medicines Code of Practice Authority (PMCPA).
The complaint accused Dr. Bourla of making “disgracefully misleading” comments about vaccinating children and that the comments were “extremely promotional in nature,” and that he violated several clauses of the code of practice by the Association of the British Pharmaceutical Industry (ABPI).
“There is simply no evidence that healthy schoolchildren in the UK are at significant risk from the SARS-COV-2 virus and to imply that they are is disgracefully misleading,” the complaint said.
PMCPA convened a code of practice panel that found that Dr. Bourla had indeed violated the code of practice in a few ways.
The violations include failure to present information to the public in a factual and balanced manner, misleading the public, and making claims that cannot be substantiated.
The UK Telegraph reported Pfizer appealed against the findings of the panel and strongly disagreed with UsForThem’s claims that the CEO violated the code of practice.
The company argued that Dr. Bourla’s remarks were based on “up-to-date scientific evidence” and they could be proven through “publicly available independent benefit-risk assessments.”
An appeal board upheld that Dr. Bourla misled the public, made claims that were unbalanced, and made unsubstantiated claims.
However, it ruled against claims that Pfizer discredited the industry, encouraged reckless use of a treatment, and did not maintain high standards.